After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$87.01K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 11, 2026
Public filing date Jun 12, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$545.4 Jun 11, 2026
First close after public filing
$549.57 Jun 15, 2026
30-day return after filing
-2.55% Through Jul 13, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
159 shares @ $547.25
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000075
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.6M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 11, 2026 $1.39M
United Therapeutics Corp UTHR Sale Jun 11, 2026 $44.52K
United Therapeutics Corp UTHR Sale Jun 11, 2026 $27.72K
United Therapeutics Corp UTHR Sale Jun 11, 2026 $313.92K
United Therapeutics Corp UTHR Sale Jun 11, 2026 $16.91K
United Therapeutics Corp UTHR Current Sale Jun 11, 2026 $87.01K
United Therapeutics Corp UTHR Sale Jun 11, 2026 $1.1M
United Therapeutics Corp UTHR Sale Jun 11, 2026 $1.06M
United Therapeutics Corp UTHR Sale Jun 11, 2026 $1.62M
United Therapeutics Corp UTHR Sale Jun 11, 2026 $771.6K
United Therapeutics Corp UTHR Sale Jun 11, 2026 $176.6K
United Therapeutics Corp UTHR Exercise Jun 11, 2026 $0